ESC Premium Access

Left atrial thrombus resolution in atrial fibrillation or flutter: results of a prospective study with rivaroxaban (X-TRA) and a retrospective observational registry providing baseline data (CLOT-AF)

Congress Session

About the speaker

Professor Gregory Yh Lip

University of Liverpool, Liverpool (United Kingdom of Great Britain & Northern Ireland)
70 presentations
4 followers

22 more presentations in this session

Is Aspirin monotherapy effective for stroke prevention in the real world? A UK cohort study evaluating the incidence of stroke in the absence of anticoagulation in atrial fibrillation (AF)

Speaker: Doctor E. Ridha (London, GB)

Thumbnail

Poor anticoagulation control in warfarin treated atrial fibrillation patients with reduced renal function

Speaker: Doctor A. Nissen Bonde (Gentofte, DK)

Thumbnail

In-hospital mortality, length of stay and costs of treating atrial fibrillation or flutter patients admitted for intracranial hemorrhage

Speaker: Doctor E. Nguyen (Storrs, US)

Thumbnail

One-year permeability rate of left atrial appendage closure devices: high incidence of peridevice leak and lack of endothelialization

Speaker: Doctor G. Laugaudin (Montpellier, FR)

Thumbnail

Net clinical benefit of rivaroxaban compared with warfarin in patients with atrial fibrillation

Speaker: Associate Professor J. Piccini (Durham, US)

Thumbnail

Access the full session

Poster session 3 - Anticoagulation in atrial fibrillation II

Speakers: Professor G. Lip, Doctor E. Ridha, Doctor A. Nissen Bonde, Doctor E. Nguyen, Doctor G. Laugaudin...
Thumbnail

About the event

Image

ESC CONGRESS 2016

27 August - 31 August 2016

Sessions Presentations

This platform is supported by

logo Novo Nordisk